Sort
50,496 grants matching “lung cancer”
miR-155 targeted therapeutics for precision medicine in lung cancer
$536,674George A. Calin · University Of Tx Md Anderson Can Ctr · R01 · FY2018 · CA
Chemical Methods for Ferrous Iron Dependent Drug Delivery
$536,653Adam R Renslo · University Of California, San Francisco · R01 · FY2022 · AI
Chemical Methods for Ferrous Iron Dependent Drug Delivery
$536,653Adam R Renslo · University Of California, San Francisco · R01 · FY2020 · AI
Chemical Methods for Ferrous Iron Dependent Drug Delivery
$536,653Adam R Renslo · University Of California, San Francisco · R01 · FY2021 · AI
Anticoagulation Treatment and Long-Term Outcomes After Venous Thromboembolism
$536,641Margaret C. Fang · University Of California, San Francisco · R01 · FY2014 · HL
Effect of Neonatal Hyperoxia on Alveolar Development and Infection
$536,581Michael A O'Reilly · University Of Rochester · R01 · FY2021 · HL
Effect of Neonatal Hyperoxia on Alveolar Development and Infection
$536,581Michael A O'Reilly · University Of Rochester · R01 · FY2020 · HL
Effect of Neonatal Hyperoxia on Alveolar Development and Infection
$536,581Michael A O'Reilly · University Of Rochester · R01 · FY2019 · HL
Multigenic copy number alterations
$536,561Scott Powers · State University New York Stony Brook · R01 · FY2019 · CA
University of Washington/Fred Hutch Center for AIDS Research
$536,547Connie L Celum · University Of Washington · P30 · FY2024 · AI
Fractionated photoimmunotherapy to harness low-dose immunostimulation in ovarian cancer
$536,528Bryan Quilty Spring · Northeastern University · U01 · FY2025 · CA
RNA-Binding Proteins as Molecular Integrators that Control the Response of HGSOC to Ant-Cancer Therapies
$536,497Michael B Yaffe · Massachusetts Institute Of Technology · R01 · FY2019 · CA
RNA-Binding Proteins as Molecular Integrators that Control the Response of HGSOC to Ant-Cancer Therapies
$536,497Michael B Yaffe · Massachusetts Institute Of Technology · R01 · FY2021 · CA
RNA-Binding Proteins as Molecular Integrators that Control the Response of HGSOC to Ant-Cancer Therapies
$536,497Michael B Yaffe · Massachusetts Institute Of Technology · R01 · FY2022 · CA
RNA-Binding Proteins as Molecular Integrators that Control the Response of HGSOC to Ant-Cancer Therapies
$536,497Michael B Yaffe · Massachusetts Institute Of Technology · R01 · FY2020 · CA
Immunologic Monitoring and Cellular Products Laboratory
$536,490Lisa Helene Butterfield · University Of Pittsburgh At Pittsburgh · P30 · FY2015 · CA
UCLA Pulmonary and Critical Care Medicine Training Program
$536,332Steven M. Dubinett · University Of California Los Angeles · T32 · FY2020 · HL
Deciphering the molecular control of intratumoral dendritic cells
$536,319Miriam Merad · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · CA
Deciphering the molecular control of intratumoral dendritic cells
$536,319Miriam Merad · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · CA
Targeting cancer stem cells in JAK2V617F induced neoplasm
$536,307Shaoguang Li · Univ Of Massachusetts Med Sch Worcester · R01 · FY2021 · CA
Targeting cancer stem cells in JAK2V617F induced neoplasm
$536,307Shaoguang Li · Univ Of Massachusetts Med Sch Worcester · R01 · FY2020 · CA
Loss of NF1 drives hormone dependent mammary carcinogenesis in a rat model with intact immune system
$536,240Deeann Wallis-Schultz · University Of Alabama At Birmingham · R01 · FY2023 · CA
Behavioral Science Core
$536,191Alan S Wayne · Division Of Basic Sciences - Nci · ZIC · FY2012 · CA
Role of PI3Kgamma in Tumor Progression and Metastasis
$535,870Judith A. Varner · University Of California, San Diego · R01 · FY2025 · CA
Role of PI3Kgamma in Tumor Progression and Metastasis
$535,870Judith A. Varner · University Of California, San Diego · R01 · FY2023 · CA